Dynix Diagnostix is a strong supporter of the American Society of Clinical Oncologists (ASCO)*, particularly with regard to their recommendations on genetic and genomic testing elaborated in the 2009 policy statement: follow-up care; increased education and awareness; multidisciplinary research; pre- and post-test counseling; informed consent; accessibility through insurance; privacy and data security; and, continued oversight for accuracy, validity and quality of genetic test and testing laboratories.
Dynix uses the latest advances in Next Generation Sequencing (NGS) to analyze a patient’s sample. Thus, providing comprehensive reports of genetic variants and risk factors. The ordering physician, supported by our genetic counselors, is able to formulate a treatment protocol to address any negative findings. Awareness of one’s risk factors allows patients and their physicians to take a proactive, rather than reactive approach to managing identified risks.
• An individual with a personal history of cancer
• An individual with one or more family members diagnosed with cancer under the age of 50
• An individual with multiple family members possessing different cancers
• An individual with a family member who has had hereditary cancer genetic testing and variants were identified
Dynix Diagnostix is an industry leading, full-service clinical laboratory. We deliver quality service and efficient results for molecular genetics, blood testing, toxicology, and pathology.
By admin Prohibitions against balance billing…
By: Jeff Cohen Healthcare professionals and…